PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

Published:2016-05-31 Issue:7 Volume:5 Page:e1176653
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Chen Chang-Long,Pan Qiu-Zhong,Zhao Jing-Jing,Wang Ying,Li Yong-Qiang,Wang Qi-Jing,Pan Ke,Weng De-Sheng,Jiang Shan-Shan,Tang Yan,Zhang Xiao-Fei,Zhang Hong-Xia,Zhou Zi-Qi,Zeng Yi-Xin,Xia Jian-Chuan

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1176653

Reference48 articles.

1. Localized and Systemic Approaches to Treating Hepatocellular Carcinoma

2. Hepatocellular carcinoma

3. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

4. Earlier presentation and application of curative treatments in hepatocellular carcinoma

5. Sorafenib in Advanced Hepatocellular Carcinoma

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating biomarkers for diagnosis and response to therapies in cancer patients;International Review of Cell and Molecular Biology;2024

2. PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-08-29

3. Expression and in vitro function of anti-PD-L1 human antibody expressed in plant;Plant Biotechnology Reports;2023-07-19

4. Noninvasive evaluation of neutrophil extracellular traps signature predicts clinical outcomes and immunotherapy response in hepatocellular carcinoma;Frontiers in Immunology;2023-07-13

5. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma;Scientific Reports;2023-05-12